Debut Biotech makes its entrance with a $22M series A for cell-free biomanufacturing facility



Two-year-old biomanufacturing upstart Debut Biotech, led by CEO Joshua Britton, has already inked partnerships with Battelle, DSM and DIC. (Debut Biotech)
https://www.fiercebiotech.com/biotech/debut-biotech-picks-up-22m-series-a-for-cell-free-biomanufacturing-facility

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.